Latest News

Latest News

News from the World Hepatitis Alliance

Industry and civil Society unite to help deliver hepatitis C medication in low-and middle-income countries

18 Jan 2017 Tara Farrell

Today, MasterCard signed a Memorandum of Understanding (MoU) with Gilead Sciences, Inc. to explore, in a pilot programme, the potential of using the...

India’s young filmmakers give a global voice to viral hepatitis survivors

14 Dec 2016 Tara Farrell

Today, media charity tve today launches four powerful films that give voice to five individuals in India who have survived viral hepatitis, one of...

Leave no-one behind

2 Dec 2016 Tara Farrell

On 3rd December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that patient-centred universal health coverage is...

HIV coinfection more than triples the risk of liver disease, liver failure and liver-related death from viral hepatitis

1 Dec 2016 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2016 –...

New WHA Executive Board announced

28 Nov 2016 Bridie Taylor

Our voting members have spoken and the votes have been counted! Following a fiercely contested election, we are delighted to announce our new...

WHO launches first-ever global report on access to hepatitis C treatment

27 Oct 2016 Tara Farrell

New report from the World Health Organization (WHO) released today shows how political will, civil society advocacy and pricing negotiations are...

Launch of World Hepatitis Day 2016 Report

19 Oct 2016 Tara Farrell

On 28 July 2016, patients, governments, organisations and many others participated the most successful World Hepatitis Day (WHD) to date, with 174...

New database sheds light on generic hep C drugs in low-and middle-income countries and how to access them

13 Oct 2016 Bridie Taylor

To provide information on the intellectual property status of priority medicines in 101 low-and middle-income countries, the Medicines Patent Pool (...

Interested in leading a global organisation in the fight to eliminate viral hepatitis?

15 Sep 2016 Bridie Taylor

The World Hepatitis Alliance (WHA) is seeking nominations for two key offices; President-Elect and Regional Executive Board Members, to drive action...

Europe Adopts Regional Action Plan to Eliminate Viral Hepatitis

14 Sep 2016 Tara Farrell

Today, representatives from the 53 countries in the WHO European Region adopted the first-ever Action Plan for viral hepatitis. The Action Plan,...

CHANGE OF DATE: WORLD HEPATITIS SUMMIT 2017

12 Sep 2016 Tara Farrell

Due to unforeseen circumstances, the Committee of the World Hepatitis Summit - comprising the World Hepatitis Alliance; World Health Organization and...

100 ACTIVISTS STAGE A “DIE-IN” TO SEND A POWERFUL MESSAGE TO WORLD LEADERS TO ELIMINATE VIRAL HEPATITIS

28 Jul 2016 Tara Farrell

On World Hepatitis Day, the World Hepatitis Alliance and The Hepatitis C Trust, held the first hepatitis “die-in” at Piccadilly Circus in London to...

Globally, 95% of people living with a cancer-causing illness are unaware

28 Jul 2016 Bridie Taylor

On World Hepatitis Day, the World Hepatitis Alliance is calling for a dramatic scale up in viral hepatitis testing to reduce liver cancer deaths...

Treatment of hepatitis C has more than doubled since 2013. Yet 99% of people are still being denied the life-saving cure

28 Jul 2016 Bridie Taylor

On World Hepatitis Day, the World Hepatitis Alliance is calling for a dramatic scale up in testing and treatment across all countries to reduce the...

Viral hepatitis is the 7th leading killer worldwide, killing more people than HIV, TB or malaria

7 Jul 2016 Tara Farrell

Viral hepatitis has become the seventh leading cause of death and disability in the world, killing more people in a year than HIV/AIDs, tuberculosis...

WHA presents Knowledge for Change webinar series to enhance hepatitis knowledge

8 Jun 2016 Bridie Taylor

Advocacy is a powerful tool but in order to effectively advocate and bring about change, it is important to first build our knowledge in key areas...

Governments on track to eliminate viral hepatitis by 2030

28 May 2016 Tara Farrell

194 Member States commit to eliminating viral hepatitis at World Health Assembly On 28 May, 194 Member States made a historic commitment to eliminate...

A make-or-break moment for the first viral hepatitis strategy

26 May 2016 Tara Farrell

REPOSTED FROM DEVEX : By Jenny Lei Ravelo @JennyLeiRavelo Six years ago, advocates against viral hepatitis experienced a huge win: Member states at...

7.1 million lives to be saved if governments agree to eliminate global killer

24 May 2016 Bridie Taylor

The World Hepatitis Alliance is calling on 194 Member States to support the adoption of the World Health Organization’s first ever Elimination...

Animated video launched to help support the adoption of WHO’s Viral Hepatitis Strategy at the World Health Assembly

23 May 2016 Tara Farrell

To coincide with the 69th World Health Assembly, the World Hepatitis Alliance has launched an animated video to showcase the importance of WHO’s...

Pages

News from infohep

What do people who inject drugs think of point-of-care HCV testing?

20 May 2019 Keith Alcorn
Point-of-care testing to diagnose HCV infection has the potential to eliminate the need for multiple appointments to confirm chronic infection. An...

World Health Organization calls for greater focus on people who inject drugs in HCV treatment scale-up plans

30 Apr 2019 Keith Alcorn
The World Health Organization (WHO) has called for greater commitments to scale up hepatitis C virus (HCV) testing and treatment services to people...

Hepatitis elimination by 2030 in doubt as countries fail to scale up diagnosis and treatment

24 Apr 2019 Keith Alcorn
Most countries will struggle to eliminate hepatitis C by 2030 due to lack of investment and political will, missing an internationally agreed target...

Emricasan misses study endpoint for improving portal hypertension in people with NASH

24 Apr 2019 Liz Highleyman
The experimental caspase inhibitor emricasan did not meet the statistical threshold for improvement of portal hypertension in people with non-...

Faecal transplants improve encephalopathy in people with advanced liver disease

24 Apr 2019 Liz Highleyman
Faecal microbiota transplantation (FMT), which helps restore a healthy mix of bacteria in the gut, can help reverse brain function impairment in...

NAFLD a rising cause of liver disease in people with HIV

23 Apr 2019 Liz Highleyman
Now that hepatitis C can be successfully treated, non-alcoholic fatty liver disease (NAFLD) is becoming an increasingly important cause of serious...

Tenofovir may lower the risk of liver cancer more than entecavir

18 Apr 2019 Liz Highleyman
People with hepatitis B who were treated with tenofovir disoproxil fumarate (TDF; Viread) were less likely to develop hepatocellular carcinoma (HCC)...

Core protein inhibitor shows promising activity against hepatitis B

16 Apr 2019 Liz Highleyman
An experimental hepatitis B virus (HBV) core protein inhibitor led to greater reductions in HBV viral load and residual HBV genetic material when...

Simplified monitoring for hepatitis C is as effective as standard monitoring

16 Apr 2019 Keith Alcorn
People who had a simplified monitoring schedule of hepatitis C viral load tests at the beginning of treatment and 12 weeks after completing treatment...

Bulevirtide is a potential cure for hepatitis B and D

16 Apr 2019 Liz Highleyman
Bulevirtide, formerly known as Myrcludex B, led to suppression of hepatitis delta virus (HDV) and a functional cure of hepatitis B virus (HBV) in...